Anebulo Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANEB and other ETFs, options, and stocks.

About ANEB

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1.

CEO

Richard Anthony Cunningham

CEORichard Anthony Cunningham

Employees

Employees3

Headquarters

Lakeway, Texas

HeadquartersLakeway, Texas

Founded

2020

Founded2020

Employees

Employees3

ANEB Key Statistics

Market cap

46.84M

Market cap46.84M

Price-Earnings ratio

-3.92

Price-Earnings ratio-3.92

Dividend yield

—

Dividend yield—

Average volume

17.37K

Average volume17.37K

High today

$1.16

High today$1.16

Low today

$1.04

Low today$1.04

Open price

$1.12

Open price$1.12

Volume

8.52K

Volume8.52K

52 Week high

$3.20

52 Week high$3.20

52 Week low

$0.8001

52 Week low$0.8001

Anebulo Pharmaceuticals

Why Robinhood?

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1. Show more

ANEB Key Statistics

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the provision of pharmaceutical services. Its product candidate, Selonabant, is a small molecule antagonist of cannabinoid binding receptor type-1.